99% Savings - Buy Just @1 Rs X
Voglase M 500 Mg/0.2 Mg Tablet is a prescription drug, available for use as Tablet. The alternative uses of Voglase M 500 Mg/0.2 Mg Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Voglase M 500 Mg/0.2 Mg Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Voglase M 500 Mg/0.2 Mg Tablet are Weakness, Headache, Nausea or vomiting. Apart from the aforementioned side effects, Voglase M 500 Mg/0.2 Mg Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Voglase M 500 Mg/0.2 Mg Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Voglase M 500 Mg/0.2 Mg Tablet is Severe for pregnant women and Severe for women who are breastfeeding. Further, the section on Voglase M 500 Mg/0.2 Mg Tablet related warnings talks about Voglase M 500 Mg/0.2 Mg Tablet's effects on the liver, heart and kidney.
Voglase M 500 Mg/0.2 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetic Ketoacidosis are examples of such conditions.
Additionally, Voglase M 500 Mg/0.2 Mg Tablet may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Voglase M 500 Mg/0.2 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Voglase M 500 Mg/0.2 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Voglase M 500 Mg/0.2 Mg Tablet safe for pregnant women?
Voglase M has many dangerous side effects in pregnant women. If you are pregnant, do not consume Voglase M without medical advice.
Is the use of Voglase M 500 Mg/0.2 Mg Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Voglase M. It should only be taken after medical advice.
What is the effect of Voglase M 500 Mg/0.2 Mg Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Voglase M. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Voglase M 500 Mg/0.2 Mg Tablet on the Liver?
You may experience side effects on your liver after taking Voglase M. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Voglase M 500 Mg/0.2 Mg Tablet on the Heart?
Voglase M has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Voglase M 500 Mg/0.2 Mg Tablet unless your doctor advises you to do so -
Is this Voglase M 500 Mg/0.2 Mg Tablet habit forming or addictive?
Voglase M 500 Mg/0.2 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Voglase M 500 Mg/0.2 Mg Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume Voglase M 500 Mg/0.2 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Voglase M 500 Mg/0.2 Mg Tablet in mental disorders is not effective.
Interaction between Food and Voglase M 500 Mg/0.2 Mg Tablet
There is no information on the effects of taking Voglase M 500 Mg/0.2 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Voglase M 500 Mg/0.2 Mg Tablet
Information about the interaction of Voglase M 500 Mg/0.2 Mg Tablet and alcohol is not currently available because this topic has not been researched yet.
Yes, Voglase M is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as dizziness, nausea, and vomiting. If you experience any discomfort after taking this medicine then inform your doctor immediately and follow his/her instructions.
Voglase M contain voglibose. It works by inhibiting the enzyme (alpha-glucosidase) that reduces the rate of digestion of complex carbohydrates. Less glucose is absorbed because the carbohydrates are not broken down into glucose molecules. Hence in this way, Voglase M reduces blood sugar levels.
No, Voglase M does not cause weight loss. It has not been reported by a patient who is taking this medicine. However, if you experience weight loss after taking this drug then it might be due to some other reason.
Yes, Voglase M can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with voglibose. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia. It is best to consult your doctor if you feel any unwanted effects.
Voglase M is the brand name for voglibose. It is an oral antidiabetic drug that belongs to the class of medicine called alpha-glucosidase inhibitor. It is used in single or combined with other drugs to treat diabetes.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826